TipRanks
Infant Bacterial Therapeutics AB (DE:9IB)
FRANKFURT:9IB
Germany Market
9IB
Infant Bacterial Therapeutics AB
RESEARCH TOOLSreports

Infant Bacterial Therapeutics AB (9IB) Cash flow

4 Followers

Infant Bacterial Therapeutics AB Cash Flow

DE:9IB's free cash flow for Q2 2026 was kr-23.19M. For the 2026 fiscal year, DE:9IB's free cash flow was decreased by kr40.80M and operating cash flow was kr-23.19M. See a summary of the company’s cash flow.
Cash Flow
Dec 25Dec 24Dec 23Dec 22Dec 21
Operating Cash Flow
kr -72.34Mkr -113.13Mkr -101.22Mkr -85.80Mkr -55.62M
Investing Cash Flow
kr 0.00kr 0.00kr -4.15Mkr -1.00Kkr 0.00
Financing Cash Flow
kr 0.00kr 2.01Mkr 96.52Mkr 1.88Mkr 91.00K
End Cash Position
kr 144.01Mkr 223.39Mkr 329.06Mkr 335.84Mkr 386.75M
Free Cash Flow
kr -72.34Mkr -113.13Mkr -101.22Mkr -85.80Mkr -55.62M
Currency in SEK

Infant Bacterial Therapeutics AB Cash Flow